GRN and Alzheimer disease: GRN polymorphisms are associated with increased risk for Alzheimer's disease (Bellenguez et al. 2022) and Parkinson's disease (Nalls et al. 2019), and may also influence cognitive aging (Rhinn and Abeliovich 2017; Tesi et al. 2024).